Cancer Research

Mammography- Gold Standard Or Pyrite Placebo?

Common Sense 101: if benefits outweigh the costs, generally people will opt in to whatever action is under consideration. If you can prevent or reduce your chance of death from cancer by early screenings at a nominal fee, you will probably get screened. No ...

Article - Becky Jungbauer - May 15 2008 - 5:00pm

Caloric Restriction- Mouse Study Says Dieting Is Better Than Exercise For Longevity

A study investigating aging in mice has found that hormonal changes that occur when mice eat significantly less may help explain an already established phenomenon: a low calorie diet can extend the lifespan of rodents, a benefit that even regular exercise ...

Article - News Staff - May 13 2008 - 11:53pm

Oncolytics Biotech Inc. Announces U.K. Phase II Clinical Trial Investigating REOLYSIN(R) In Combination With Paclitaxel And Carb

CALGARY, Canada, May 14 /PRNewswire/-- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for its ...

Article - Anna Ohlden - May 14 2008 - 1:31am

Rosetta Genomics Announces Conference Call And Webcast Of First Quarter Financial Results

REHOVOT, Israel and JERSEY CITY, New Jersey, May 14 /PRNewswire/-- Rosetta Genomics (Nasdaq: ROSG), today announced it will release first quarter financial results on May 21, 2008, before the U.S. markets open. Rosetta Genomics will host a conference call ...

Article - Anna Ohlden - May 14 2008 - 8:31am

Reduced Dietary Fat Prevents Prostate Cancer In Mice

Scientists with UCLA’s Jonsson Cancer Center and the Department of Urology have showed that lowering intake of the type of fat common in a Western diet helps prevent prostate cancer in mice, the first finding of its kind in a mouse model that closely mimic ...

Article - News Staff - May 14 2008 - 11:56pm

New Roche Data To Be Presented At ASCO Offers Further Hope For Cancer Patients

BASEL, Switzerland, May 16 /PRNewswire/-- Patients with breast or colorectal cancer, two of the world's most common cancers, can expect further treatment advances with Avastin(R) (bevacizumab) and Herceptin(R) (trastuzumab) following new data that is ...

Article - Anna Ohlden - May 15 2008 - 8:31pm

Neighborhood Correlation- Understanding Evolution Of Multi-Domain Genes

Identifying gene ancestry is crucial for computational genomics because genes passed down from a common ancestor tend to perform similar functions in the cell. Scientists exploit this similarity in tasks like predicting gene function, mapping human chromos ...

Article - News Staff - May 15 2008 - 8:37pm

What Makes Cells Tick? Reverse Engineering Biological Cycles

Physics can explain the cycle of the earth around the sun, but what drives cellular cycles? Two of the most important cycles in cells are the series of events that take place when cells divide, and circadian rhythms- the cycle of day-night events that even ...

Article - Michael White - May 16 2008 - 8:24am

Vitamin D And Breast Cancer Linked Again

Using newly available data on worldwide cancer incidence, researchers at the Moores Cancer Center at University of California, San Diego (UCSD) and the Department of Family and Preventive Medicine have shown a clear association between deficiency in exposu ...

Article - News Staff - May 16 2008 - 12:15am

Eisai's Commitment To Oncology Demonstrated By Clinical Data To Be Presented At ASCO Annual Meeting

LONDON, May 16 /PRNewswire/-- Eisai Europe Ltd announced today that results from 9 clinical data abstracts about compounds in the company's oncology pipeline, product portfolio and preclinical oncology research have been accepted for presentation at ...

Article - Anna Ohlden - May 16 2008 - 1:31am